Search

Robert M. Kelly

Examiner (ID: 8, Phone: (571)272-0729 , Office: P/1633 )

Most Active Art Unit
1633
Art Unit(s)
1631, 1638, 1633, 1632
Total Applications
1411
Issued Applications
804
Pending Applications
145
Abandoned Applications
496

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 20178366 [patent_doc_number] => 20250262324 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-21 [patent_title] => Circular RNA Compositions [patent_app_type] => utility [patent_app_number] => 19/200761 [patent_app_country] => US [patent_app_date] => 2025-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 82724 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19200761 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/200761
Circular RNA Compositions May 6, 2025 Pending
Array ( [id] => 20178366 [patent_doc_number] => 20250262324 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-21 [patent_title] => Circular RNA Compositions [patent_app_type] => utility [patent_app_number] => 19/200761 [patent_app_country] => US [patent_app_date] => 2025-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 82724 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19200761 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/200761
Circular RNA Compositions May 6, 2025 Pending
Array ( [id] => 20099031 [patent_doc_number] => 20250228967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-17 [patent_title] => AAV CAPSID VARIANTS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 19/097114 [patent_app_country] => US [patent_app_date] => 2025-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 134940 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19097114 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/097114
AAV capsid variants and uses thereof Mar 31, 2025 Issued
Array ( [id] => 20032053 [patent_doc_number] => 20250170275 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-29 [patent_title] => METHODS AND MEANS FOR THE PREVENTION AND/OR TREATMENT OF HEMOPHILIC ARTHROPATHY IN HEMOPHILIA [patent_app_type] => utility [patent_app_number] => 19/046845 [patent_app_country] => US [patent_app_date] => 2025-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3121 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19046845 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/046845
METHODS AND MEANS FOR THE PREVENTION AND/OR TREATMENT OF HEMOPHILIC ARTHROPATHY IN HEMOPHILIA Feb 5, 2025 Pending
Array ( [id] => 20032053 [patent_doc_number] => 20250170275 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-29 [patent_title] => METHODS AND MEANS FOR THE PREVENTION AND/OR TREATMENT OF HEMOPHILIC ARTHROPATHY IN HEMOPHILIA [patent_app_type] => utility [patent_app_number] => 19/046845 [patent_app_country] => US [patent_app_date] => 2025-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3121 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19046845 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/046845
METHODS AND MEANS FOR THE PREVENTION AND/OR TREATMENT OF HEMOPHILIC ARTHROPATHY IN HEMOPHILIA Feb 5, 2025 Pending
Array ( [id] => 20032053 [patent_doc_number] => 20250170275 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-29 [patent_title] => METHODS AND MEANS FOR THE PREVENTION AND/OR TREATMENT OF HEMOPHILIC ARTHROPATHY IN HEMOPHILIA [patent_app_type] => utility [patent_app_number] => 19/046845 [patent_app_country] => US [patent_app_date] => 2025-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3121 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19046845 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/046845
METHODS AND MEANS FOR THE PREVENTION AND/OR TREATMENT OF HEMOPHILIC ARTHROPATHY IN HEMOPHILIA Feb 5, 2025 Pending
63/834389 SYNTHETIC CANCER-SPECIFIC PROMOTERS Jan 21, 2025 Pending
Array ( [id] => 19707893 [patent_doc_number] => 20250018035 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-16 [patent_title] => METHOD FOR EFFICIENTLY INFECTING HUMAN NATURAL KILLER CELLS AND OTHER IMMUNE CELLS WITH PSEUDOVIRUS [patent_app_type] => utility [patent_app_number] => 18/900968 [patent_app_country] => US [patent_app_date] => 2024-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6020 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18900968 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/900968
Method for efficiently infecting human natural killer cells and other immune cells with pseudovirus Sep 29, 2024 Issued
Array ( [id] => 19968484 [patent_doc_number] => 12337068 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-06-24 [patent_title] => Lipid nanoparticle compositions and uses thereof [patent_app_type] => utility [patent_app_number] => 18/886134 [patent_app_country] => US [patent_app_date] => 2024-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 195 [patent_figures_cnt] => 228 [patent_no_of_words] => 58745 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18886134 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/886134
Lipid nanoparticle compositions and uses thereof Sep 15, 2024 Issued
Array ( [id] => 20212592 [patent_doc_number] => 12409226 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-09 [patent_title] => Delivery and formulation of engineered nucleic acids [patent_app_type] => utility [patent_app_number] => 18/821057 [patent_app_country] => US [patent_app_date] => 2024-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 25 [patent_no_of_words] => 39777 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18821057 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/821057
Delivery and formulation of engineered nucleic acids Aug 29, 2024 Issued
Array ( [id] => 20115079 [patent_doc_number] => 12364763 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-07-22 [patent_title] => Delivery and formulation of engineered nucleic acids [patent_app_type] => utility [patent_app_number] => 18/820652 [patent_app_country] => US [patent_app_date] => 2024-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 25 [patent_no_of_words] => 39844 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18820652 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/820652
Delivery and formulation of engineered nucleic acids Aug 29, 2024 Issued
Array ( [id] => 19845315 [patent_doc_number] => 20250090666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-20 [patent_title] => DELIVERY AND FORMULATION OF ENGINEERED NUCLEIC ACIDS [patent_app_type] => utility [patent_app_number] => 18/820609 [patent_app_country] => US [patent_app_date] => 2024-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44943 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18820609 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/820609
Delivery and formulation of engineered nucleic acids Aug 29, 2024 Issued
Array ( [id] => 19799012 [patent_doc_number] => 20250064937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-27 [patent_title] => DELIVERY AND FORMULATION OF ENGINEERED NUCLEIC ACIDS [patent_app_type] => utility [patent_app_number] => 18/821068 [patent_app_country] => US [patent_app_date] => 2024-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44943 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18821068 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/821068
Delivery and formulation of engineered nucleic acids Aug 29, 2024 Issued
Array ( [id] => 20212592 [patent_doc_number] => 12409226 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-09 [patent_title] => Delivery and formulation of engineered nucleic acids [patent_app_type] => utility [patent_app_number] => 18/821057 [patent_app_country] => US [patent_app_date] => 2024-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 25 [patent_no_of_words] => 39777 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18821057 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/821057
Delivery and formulation of engineered nucleic acids Aug 29, 2024 Issued
Array ( [id] => 20212592 [patent_doc_number] => 12409226 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-09 [patent_title] => Delivery and formulation of engineered nucleic acids [patent_app_type] => utility [patent_app_number] => 18/821057 [patent_app_country] => US [patent_app_date] => 2024-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 25 [patent_no_of_words] => 39777 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18821057 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/821057
Delivery and formulation of engineered nucleic acids Aug 29, 2024 Issued
Array ( [id] => 19903127 [patent_doc_number] => 12280111 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-04-22 [patent_title] => Gene-regulating compositions and methods for improved immunotherapy [patent_app_type] => utility [patent_app_number] => 18/796740 [patent_app_country] => US [patent_app_date] => 2024-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 34 [patent_no_of_words] => 78363 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18796740 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/796740
Gene-regulating compositions and methods for improved immunotherapy Aug 6, 2024 Issued
Array ( [id] => 19658816 [patent_doc_number] => 20240425881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-26 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING NON-AGE-ASSOCIATED HEARING IMPAIRMENT IN A HUMAN SUBJECT [patent_app_type] => utility [patent_app_number] => 18/777787 [patent_app_country] => US [patent_app_date] => 2024-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 109512 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18777787 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/777787
Compositions and methods for treating non-age-associated hearing impairment in a human subject Jul 18, 2024 Issued
Array ( [id] => 19871472 [patent_doc_number] => 12264317 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-04-01 [patent_title] => Compositions and methods for treating non-age-associated hearing impairment in a human subject [patent_app_type] => utility [patent_app_number] => 18/777187 [patent_app_country] => US [patent_app_date] => 2024-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 16 [patent_no_of_words] => 90808 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18777187 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/777187
Compositions and methods for treating non-age-associated hearing impairment in a human subject Jul 17, 2024 Issued
Array ( [id] => 19722677 [patent_doc_number] => 20250025428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-23 [patent_title] => COMPOSITIONS AND METHODS FOR DELIVERING MOLECULES [patent_app_type] => utility [patent_app_number] => 18/765147 [patent_app_country] => US [patent_app_date] => 2024-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25838 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18765147 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/765147
COMPOSITIONS AND METHODS FOR DELIVERING MOLECULES Jul 4, 2024 Pending
Array ( [id] => 19570464 [patent_doc_number] => 20240374756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-14 [patent_title] => AAV CAPSID VARIANTS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/757141 [patent_app_country] => US [patent_app_date] => 2024-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 139705 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18757141 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/757141
AAV capsid variants and uses thereof Jun 26, 2024 Issued
Menu